Contribution of different mechanisms to aminoglycoside resistance in clinical isolates of Acinetobacter baumannii. 2023

Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
Microbiology Department, Egyptian Drug Authority (EDA) (former National Organization for Drug Control and Research, NODCAR), 14281, Giza, Egypt. Electronic address: salehneveen@yahoo.com.

The antibiotics overuse for infection treatment was the sparkle in the spreading of multi-drug resistance Acinetobacter baumannii in hospitals. In our study, we evaluated the contribution of the aminoglycoside resistance mechanisms of A. baumannii to the resistance surge in some selected Egyptian hospitals with a checkerboard assay application to retrieve the aminoglycoside activity. The resistance profile analysis of collected 200 A. baumannii isolates revealed a multidrug-resistant pattern with limited susceptibilities to aminoglycosides. Analysis of the prevalence of aminoglycoside-modifying enzyme (AMEs) genes revealed the presence of the six AMEs genes either singly or in combination in selected isolates and aph (3)-VIa gene was the predominant one. At the same time, four efflux pump genes of AdeABC and AdeKJL family showed significant (P < 0.001) up-regulation levels. Moreover, the implementation of combination strategy showed fourteen synergistic activities against two high-level aminoglycoside-resistance (HLAR) A. baumannii isolates. The findings highlighted the alarming levels of aminoglycoside resistance in A. baumannii isolates, which proved that a common enzymatic modification mechanism acts synergistically with decreased antibiotic accumulation in acquiring aminoglycoside resistance. Additionally, the study provides useful information for the promising synergistic combination therapy that reduces the therapeutic dose of aminoglycosides used and subsequently increases their clinical application.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004534 Egypt A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo. Arab Republic of Egypt,United Arab Republic
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug
D040981 Acinetobacter baumannii A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics. Bacterium anitratum

Related Publications

Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
July 2019, Clinical laboratory,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
February 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
October 2014, Jundishapur journal of microbiology,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
June 2019, Annals of burns and fire disasters,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
April 2016, Mikrobiyoloji bulteni,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
January 2017, Diagnostic microbiology and infectious disease,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
January 2016, PloS one,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
August 2009, Journal of medical microbiology,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
July 2019, mBio,
Neveen M Saleh, and Sarah I Saad, and Mohamed El-Sayed, and Gharieb S El-Sayyad, and Feriala A Abo Safe
June 2002, The Korean journal of internal medicine,
Copied contents to your clipboard!